Belgium· BE-AMP-SAM230045-00
Vidisic Edo 2 mg/g
A künstliche tränenflüssigkeit und sonstige indifferente präparate product containing carbomers, registered in Belgium by Bausch & Lomb Pharma. The same ATC class is registered in 11 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Künstliche tränenflüssigkeit und sonstige indifferente präparate is registered in 11 of 19 countries.
Countries holding a registration under ATC S01XA20 (künstliche tränenflüssigkeit und sonstige indifferente präparate), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Künstliche tränenflüssigkeit und sonstige indifferente präparate · ATC S01XA20
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Carbomers
- Manufacturer
- Bausch & Lomb Pharma
- Country
- Belgium (BE)
- ATC code
- S01XA20
- ATC class
- Künstliche Tränenflüssigkeit und sonstige indifferente Präparate
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb1686534
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under S01XA20
Künstliche tränenflüssigkeit und sonstige indifferente präparate, as other registers publish it.
- BelgiumAlcon Eye Gel 3 mg/gAlcon
- CanadaALCON TEARS 0.5%ALCON CANADA INC
- CanadaALCON TEARS 1%ALCON CANADA INC
- CanadaAMO ENDOSOL SOLUTIONAMO CANADA COMPANY
- DenmarkArtelacBausch & Lomb Ireland Limited
- FinlandArtelacBausch + Lomb Ireland Limited
- FinlandArtelacBausch + Lomb Ireland Limited
- NorwayArtelacBAUSCH + LOMB IRELAND LIMITED
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f2d2ad5a-01ab-4da5-8978-3f669ca12499 GET /v1/drugs/f2d2ad5a-01ab-4da5-8978-3f669ca12499?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Eye gel",
"source": "afmps",
"status": "REVOKED",
"name_en": "Vidisic Edo 2 mg/g",
"name_fr": "Vidisic Edo 2 mg/g",
"name_nl": "Vidisic Edo 2 mg/g",
"amp_code": "SAM230045-00",
"strengths": [
"2.0000"
],
"pack_count": 3,
"substances": [
"Carbomers"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Artificial Tears and Other Indifferent Preparations",
"authorisation_numbers": [
"BE230045"
]
}See everything about künstliche tränenflüssigkeit und sonstige indifferente präparate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.